Back
Speaker illustration

Doctor Masaki Nakagaito

University of Toyama, Toyama (Japan)

Presentations

Short-term effects of dapagliflozin versus canagliflozin on acute decompensated heart failure in patients with type 2 diabetes

Event: ESC Congress 2019

Topic: Pharmacotherapy

Session: Acute heart failure : new treatment updates

Access
Like
Thumbnail

Short term effect of SGLT2 inhibitor, Dapagliflozin added on to standard therapy in decompensated heart failure patients with diabetes mellitus

Event: ESC Congress 2017

Topic: AHF - Drug treatment

Session: Fresh look at heart failure

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources